All Type of News
Domestic Firms Eye on Original Drug Patent Expirations
The domestic pharmaceutical firms are strategically observing on the current and upcoming patent expirations of the blockbuster drugs, with their annual sales surpassing over $1 billion USD on an individual brand basi...
Different OTC Retail Prices Drive Public Dissatisfaction
The retail pharmacist community is raising concerns for the increased level of public dissatisfactions and mistrusts on the sales of over-the-counter (OTC) products, driven by a series of distribution price increases ...
Chairman and CEO of Novartis AG Makes Visit to Nation
Chairman and Chief Executive Officer Daniel Vasella of Novartis AG recently made a visit to the nation for the first time, where he had an opportunity to make close observations on the business growth prospects for th...
Il-yang Makes Licensing Agreement for Grupo Uriach's Rupafin
Il-yang Pharmaceutical Co. announced last week that the company signed an exclusive domestic licensing agreement for Rupafin (rupatadine fumarate), a novel antihistamine agent for the management of diseases with aller...
KFDA Approves Extended Pediatric Application of LactiCare-HC
Stiefel Korea recently announced that the Korea Food and Drug Administration (KFDA) has given an approval on the extended pediatric application of LactiCare-HC (active ingredient: hydrocortisone) Lotion for the treatm...
April Parliamentary Session Begins with Uncertain Outcome for Pharmaceutical Reform Bill
The domestic pharmaceutical industry is giving its close attention to the National Assembly spring session, which has officially started from April 6th, on the proposed Korea Pharmaceutical Affairs Law (KPAL) reform b...
KFDA to Announce Detailed Outline for Small-Unit Packaging Requirement
It is expected that the detailed outline for the proposed small-unit packaging requirement as applicable the pharmaceutical products will be generated after a completion of contract-based work efforts requested by the...
Pharmaceutical Firms Consider New Ways to Evaluate Wholesale Distribution Partners
The domestic pharmaceutical firms are looking to move away from the existing evaluation method that has influenced the contractual relationships with their wholesale distribution partners, in which the standard indust...
KFDA Approves Phase III Clinical Trial for Aropotin
TS Corporation announced on April 6th that the Korea Food and Drug Administration (KFDA) has approved the phase III clinical trial for Aropotin, an independently developed, bioengineered treatment for the anemia assoc...
Active GMP Accreditation Requests by Domestic Nutraceutical Companies
The active level of applications submitted by the domestic nutraceutical companies for attaining a GMP (Good Manufacturing Practice) accreditation is paving a pathway towards the safe and high-quality production of nu...
